Book an appointment

Psychiatry - New Patient

With every initial visit appointment, the patient spends 50-60 minutes with the provider, who conducts a thorough diagnostic assessment via interview, records mental health symptoms, and reviews medical history, psycho-social and developmental history, family history, substance use history, and review lab work when indicated. The MWI Psychiatrist or Mental Health NP will then make an accurate and educated diagnoses of the mental health condition and customize a personal treatment plan involving a combination of therapies including psychotherapy, behavioral modification, and medication.

$250 · 1 hour

Psychiatry - Existing Patient Medication Management

Medication Management appointments for patients who have previously seen the provider are brief, lasting only 20 minutes or less. During these appointments, the patient’s response to medications will be reviewed and assessed, and side effects noted, with changes to medications being made as necessary and refills completed. The patient will receive some supportive therapy during these appointments, with referrals made for the best overall mental health treatment.

$120 · 20 minutes

Suboxone Treatment Clinic - New Patient

We are certified for Suboxone treatment, giving hope for people addicted to opioids. Our supportive care team of specially-trained Suboxone treatment providers offer solutions for opioid addiction on the 1st and 3rd Wednesdays of every month in our specialty clinic in Flandreau, South Dakota, located only 45 minutes north of Sioux Falls. Telehealth appointments considered on a case-by-case basis only. Our providers have given addicts new hope through established treatment plans amidst a national opioid crisis, offering in-person and telehealth care to individuals caught in the cycle of pain killer dependence. Our Buprenorphine-Certified staff are currently welcoming new patients that are dedicated to getting on the path to recovery.

$250 · 1 hour

Suboxone Treatment Clinic - Existing Patient

Our supportive care team of specially-trained Buprenorphine-Certified providers guide clients previously caught in the grips of opioid addiction as they focus on complete wellness with the assistance of suboxone. We hold our Suboxone Treatment Clinics on the 1st and 3rd Wednesdays of each month. Appointments are available on the 1st and 3rd Wednesdays of every month in our specialty clinic in Flandreau, South Dakota, with telehealth appointments provided on a case-by-case basis. Our providers have given addicts new hope through established treatment plans, access to emotional support, and resources for a better life.

$150 · 30 minutes

Dr. Abbey Kitto

Abbey graduated Magna Cum Laude from South Dakota State University with a Bachelor of Science Degree in Nursing in 2006. Following graduation, she worked as a RN in the surgical fields of general surgery, plastic surgery, and ophthalmology. In 2010, she returned to SDSU to complete the Doctor of Nursing Practice (DNP) program and graduated with her doctorate degree in August of 2015. Abbey guides individuals through the battle of opioid addiction at our Suboxone treatment clinic in Flandreau, SD, as well providing mental health treatment.

Dr. Clay Pavlis

Dr. Clay Pavlis, M.D., earned his BS in Biology after graduation Summa Com Laude from South Dakota State University in Brookings, SD. He attended Medical School at the University of Minnesota – Duluth and the University of South Dakota School of Medicine, becoming board-certified in Adult Psychiatry by the American Board of Psychiatry and Neurology. Dr. Pavlis’s vision for providing personalized care, along with the goal of leading a team of providers that are focused on excellence, was the catalyst for establishing Midwest Wellness Institute in 2012. As MWI’s chief psychiatrist and medical officer, Dr. Pavlis’s leadership is vital to our growing team of providers. Dr. Pavlis specializes in conducting forensic evaluations, independent psychiatric evaluations, VA services, medication management, addiction medicine, neuromodulation, and psychopharmacologenomics.